Details for Patent: 6,544,967
✉ Email this page to a colleague
| Title: | Method for inhibiting bone resorption |
| Abstract: | Disclosed are methods for inhibiting bone resorption in mammals while minimizing the occurrence of or potential for adverse gastrointestinal effects. Also disclosed are pharmaceutical compositions and kits for carrying out the therapeutic methods disclosed herein. |
| Inventor(s): | Daifotis; Anastasia G. (Westfield, NJ), Santora, II; Arthur C. (Watchung, NJ), Yates; A. John (Westfield, NJ) |
| Assignee: | Merck & Co., Inc. (Rahway, NJ) |
| Filing Date: | Jan 08, 2001 |
| Application Number: | 09/756,562 |
| Claims: | 1. A pharmaceutical composition comprising about 140 mg, on an alendronic acid active basis, of a bisphosphonate selected from the group consisting of alendronate, pharmaceutically acceptable salts or esters thereof, and mixtures thereof. 2. A pharmaceutical composition according to claim 1 wherein said pharmaceutically acceptable salt is selected from the group consisting of sodium, potassium, calcium, magnesium, and ammonium salts. 3. A pharmaceutical composition according to claim 2 wherein said pharmaceutically acceptable salt is a sodium salt. 4. A pharmaceutical composition according to claim 3 wherein said pharmaceutically acceptable salt is alendronate monosodium trihydrate. 5. A pharmaceutical composition according to claim 1 in the form of a tablet. 6. A pharmaceutical composition according to claim 2 in the form of a tablet. 7. A pharmaceutical composition according to claim 3 in the form of a tablet. 8. A pharmaceutical composition according to claim 4 in the form of a tablet. 9. A pharmaceutical composition according to claim 1 in the form of a capsule. 10. A pharmaceutical composition according to claim 2 in the form of a capsule. 11. A pharmaceutical composition according to claim 3 in the form of a capsule. 12. A pharmaceutical composition according to claim 4 in the form of a capsule. 13. A pharmaceutical composition according to claim 1 in the form of a liquid. 14. A pharmaceutical composition according to claim 2 in the form of a liquid. 15. A pharmaceutical composition according to claim 3 in the form of a liquid. 16. A pharmaceutical composition according to claim 4 in the form of a liquid. 17. A pharmaceutical composition according to any of claims 1-16 wherein said pharmaceutical composition is an oral composition. |
